CARCINOID HEART DISEASE

This adverse event was reported 91 times

These drugs are most commonly taken by patients reporting CARCINOID HEART DISEASE:

# Drug Count
0 OCTREOTIDE ACETATE 45
1 OCTREOTIDE 19
2 CITALOPRAM 14
3 CITALOPRAM HYDROBROMIDE 14
4 LUTETIUM LU 177 DOTATATE 13
5 EVEROLIMUS 9
6 FUROSEMIDE 8
7 LANREOTIDE ACETATE 8
8 AMLODIPINE 6
9 PANCRELIPASE 5
See all common drugs associated with CARCINOID HEART DISEASE

CARCINOID HEART DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MENADIONE 1 0.0072
1 LUTETIUM LU 177 DOTATATE 13 0.0022
2 PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE 1 0.0015
3 OCTREOTIDE ACETATE 45 0.0015
4 LANREOTIDE ACETATE 8 0.0010
5 SENNA LAXATIVE 1 0.0008
6 TELOTRISTAT ETHYL 4 0.0007
7 TRANDOLAPRIL TABLETS 1 0.0005
8 EVEROLIMUS TABLETS 4 0.0002
9 FLECAINIDE ACETATE 1 0.0002
See all drugs enriched for association with CARCINOID HEART DISEASE

CARCINOID HEART DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 19 0.0028
1 Serotonin Reuptake Inhibitor [EPC] 13 0.0001
2 Cannabinoid [EPC] 1 0.0001
3 Thiazide-like Diuretic [EPC] 2 0.0000
4 Bile Acid [EPC] 1 0.0000
5 Loop Diuretic [EPC] 11 0.0000
6 Folate Analog [EPC] 1 0.0000
7 Vitamin A [EPC] 1 0.0000
8 Aldosterone Antagonist [EPC] 3 0.0000
9 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
See all drug classes enriched for association with CARCINOID HEART DISEASE